Medical device mark-up debate prompts industry calls for trade margin rationalisation

Medical technology associations and hospital bodies have reportedly supported Trade Margin Rationalisation (TMR) following a Maharashtra Food and Drug Administration (FDA) survey revealing large price mark-ups on medical consumables. Industry representatives backed establishing clear guidelines on permissible gaps between procurement costs and printed maximum retail prices, while distinguishing complex technologies from commoditised consumables.